-
Type | Notes
------------ | -------------
Item | Trial Enrollment information in OBSERVATION table
Forum Post | http://forums.ohdsi.org/t/omop-cdm-and-clinical-trials/2109
SOLUTION
To repres…
-
Thanks you for your excellent works, I want to know whether this work is a equal way to augment data.
-
Hi,
Great work and thank you for the resource. The demographic and clinical data for the CS group doesn't match the Paper. Just an FYI.
Cheers
-
https://doi.org/10.1101/159756 (http://www.biorxiv.org/content/early/2017/07/05/159756.1)
> Though it is widely recognized that data sharing enables faster scientific progress, the sensible need to…
-
The description of the attribute Pregnancy_status in the day0 schema is "Is the case pregnant or post-partum?". Pregnancy and post-partum are distinct concepts in SNOMED-CT. These are also separate co…
-
Suggestion: the front page now shows in the top right Clinical NLP and LiLaH. It'd look nicer in my opinion if instead of the project name LiLaH we have something more general, like NLP for hate speec…
-
which column in the clinical_data should i consider to know if the tumor has recurred or not?
does _RFS_IND=1 mean definitely recurred?
how do i know if the tumor is primary or second primary?…
-
Goal is to prepare for V4 - where AccessPolicies will be required by default on all `ProjectMembership`
Currently, [Access Policies](https://www.medplum.com/docs/auth/access-control) need to be cre…
-
SME team should provide the content from a clinical perspective
Also include a description of what changes were made to the evidence type and recommendation strength categories
-
Hello,
i have integrated two links into a template as follows.
```